Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics

被引:154
作者
Allen, Richard P. [1 ]
Stillman, Paul [1 ]
Myers, Andrew J. [1 ]
机构
[1] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21224 USA
关键词
Restless legs syndrome; RLS; Prevalence; Medical significance; Clinical significance; Sleep disorder; Insomnia; Quality of life; SLEEP LOSS; SYNDROME RLS; VALIDATION; IMPACT; IRON; RISK; SYMPTOMS; FERRITIN; OUTCOMES; OBESITY;
D O I
10.1016/j.sleep.2009.03.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Background: Restless legs syndrome (RLS) is a medical condition with established neuropathology and genetic associations. Significant questions have, however, recently been raised about its true prevalence, medical significance and the degree to which it is under or over-diagnosed. This study therefore aimed to determine its prevalence, morbidity and adequacy of diagnosis based on physician evaluations of their own patients in primary care practice. Methods: Screening questionnaires were completed by adult patients attending 62 primary care practices across six western European countries within a one-week period. Patients Screening positive for significant RLS symptoms Were clinically evaluated for RLS by their physician. Physicians also classified the degree RLS affected the patient's health and well-being. Patients independently completed the SF-36 Quality of Life and Medical Outcomes Study (MOS) sleep questionnaires. Results: Ten thousand five hundred and sixty-four patients completed the screening questionnaire: 804 responded positively to RLS symptoms and 630 of these were subsequently evaluated by their physician. The physicians diagnosed RLS in 365 patients. Ninety-one percent of these had not been previously diagnosed with RLS. In this cohort of adult primary care patients (without or with prorating for missed interviews) the estimated prevalence for diagnosed RLS was 3.5% or 4.4% and for medically-significant RLS 2.1% or 2.7%. A moderate to high degree of RLS negative impact on health related strongly to a lower vitality subscale on the SF-36 and short sleep times (5.2-5.4 h) with more sleep disturbance on the MOS sleep scale. Conclusion: RLS in these western European countries is a common, clinically-significant medical condition that, despite all the publicity, remains largely undiagnosed. RLS evaluation is particularly recommended for patients complaining of insomnia. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 32 条
[1]
Dopamine and iron in the pathophysiology of restless legs syndrome (RLS) [J].
Allen, R .
SLEEP MEDICINE, 2004, 5 (04) :385-391
[2]
Validation of the Johns Hopkins restless legs severity scale [J].
Allen, Richard P. ;
Earley, Christopher J. .
SLEEP MEDICINE, 2001, 2 (03) :239-242
[3]
Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep) [J].
Allen, Richard P. ;
Kosinski, Mark ;
Hill-Zabala, Christina E. ;
Calloway, Michael O. .
SLEEP MEDICINE, 2009, 10 (05) :531-539
[4]
Restless legs syndrome prevalence and impact - REST general population study [J].
Allen, RP ;
Walters, AS ;
Montplaisir, J ;
Hening, W ;
Myers, A ;
Bell, TJ ;
Ferini-Strambi, L .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) :1286-1292
[5]
MRI measurement of brain iron in patients with restless legs syndrome [J].
Allen, RP ;
Barker, PB ;
Wehrl, F ;
Song, HK ;
Earley, CJ .
NEUROLOGY, 2001, 56 (02) :263-265
[6]
Sex and the risk of restless legs syndrome in the general population [J].
Berger, K ;
Luedemann, J ;
Trenkwalder, C ;
Ulrich, J ;
Kessler, C .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (02) :196-202
[7]
Ferritin levels in the cerebrospinal fluid and restless legs syndrome: Effects of different clinical phenotypes [J].
Earley, CJ ;
Connor, JR ;
Beard, JL ;
Clardy, SL ;
Allen, RP .
SLEEP, 2005, 28 (09) :1069-1075
[8]
Restless legs syndrome [J].
Earley, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (21) :2103-2109
[9]
Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls [J].
Gamaldo, Charlene ;
Benbrook, Amy R. ;
Allen, Richard P. ;
Oguntimein, Oluwamurewa ;
Earley, Christopher J. .
SLEEP MEDICINE, 2009, 10 (01) :134-138
[10]
Effect of Celecoxib, a Cyclooxygenase-2-Specific Inhibitor, on Insulin Sensitivity, C-Reactive Protein, Homocysteine, and Metabolic Profile in Overweight or Obese Subjects [J].
Gonzalez-Ortiz, Manuel ;
Pascoe-Gonzalez, Sara ;
Esperanzamartinez-Abundis ;
Kam-Ramos, Angelica M. ;
Hernandez-Salazar, Eduardo .
METABOLIC SYNDROME AND RELATED DISORDERS, 2005, 3 (02) :95-101